Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Acerus Pharmaceuticals Corp ASPCQ

Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.


OTCPK:ASPCQ - Post by User

Post by PitchinPennieson May 16, 2023 7:48am
141 Views
Post# 35449776

Joshing aside, where's the class-action suit against Ian?

Joshing aside, where's the class-action suit against Ian?Surely there's a litigation firm that will take this on under a contingency agreement? Ian's still got plenty of dough squirreled away, and someone needs to pay for the 10-year destruction of shareholder value under serial incompetent CEOs, up to and including "Slow-as-a-Sunday-in-Welland" Eddie.

A quick Google search reveals half a dozen U.S. based law firms that specialize in this type of situation, and say they want no fee upfront. So, what are we waiting for? 
<< Previous
Bullboard Posts
Next >>